BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17374990)

  • 21. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
    Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
    Du YH; Ho PC
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.
    Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P
    Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
    Alemany M; Levin J
    Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway.
    Chen MJ; Yang PY; Ye YZ; Hu DN; Chen MF
    Am J Chin Med; 2010; 38(6):1131-42. PubMed ID: 21061466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.
    Mann KK; Padovani AM; Guo Q; Colosimo AL; Lee HY; Kurie JM; Miller WH
    J Clin Invest; 2005 Oct; 115(10):2924-33. PubMed ID: 16184197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
    Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
    Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage.
    Mahieux R; Pise-Masison C; Gessain A; Brady JN; Olivier R; Perret E; Misteli T; Nicot C
    Blood; 2001 Dec; 98(13):3762-9. PubMed ID: 11739184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
    Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
    Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.
    Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells.
    Um SJ; Lee SY; Kim EJ; Myoung J; Namkoong SE; Park JS
    Cancer Lett; 2002 Jul; 181(1):11-22. PubMed ID: 12430174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
    Karlsson J; Øra I; Pörn-Ares I; Påhlman S
    Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of As2O3 induces apoptosis of glioma U87 cells.
    Wang GB; Liu JH; Hu J; Xue K
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4875-4881. PubMed ID: 29164574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indomethacin-enhanced anticancer effect of arsenic trioxide in A549 cell line: involvement of apoptosis and phospho-ERK and p38 MAPK pathways.
    Mandegary A; Torshabi M; Seyedabadi M; Amirheidari B; Sharif E; Ghahremani MH
    Biomed Res Int; 2013; 2013():237543. PubMed ID: 24312908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells.
    Baysan A; Yel L; Gollapudi S; Su H; Gupta S
    Int J Oncol; 2007 Feb; 30(2):313-8. PubMed ID: 17203211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.
    Zheng Y; Zhou M; Ye A; Li Q; Bai Y; Zhang Q
    World J Surg Oncol; 2010 Apr; 8():31. PubMed ID: 20403207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
    Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
    Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
    Cheng B; Yang X; An L; Gao B; Liu X
    Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.